Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven E Lipshultz

Showing results (41-50 of 284) with videos related to

Pageof 29
Sort By:
Translational Pediatrics|November 22, 2018
When is early septal myectomy in children with hypertrophic cardiomyopathy justified?Neha Bansal, Paul Barach, Shahnawaz M Amdani, et al.
American Heart Journal|February 26, 2008
Associations between neurohormonal and inflammatory activation and heart failure in childrenChristopher Ratnasamy, Daniel D Kinnamon, Steven E Lipshultz, et al.
Cardio-Oncology (London, England)|February 3, 2021
An Invitation from the Editors of Cardio-OncologySteven E Lipshultz, Giorgio Minotti, Joseph Carver, et al.
JAMA|March 19, 2026
Caffeinated Coffee and Atrial FibrillationSachin A Shah, Steven E Lipshultz, N A Mark Estes
British Journal of Clinical Pharmacology|September 5, 2016
Prevention of cardiotoxicity among survivors of childhood cancerKelley K Hutchins, Hani Siddeek, Vivian I Franco, et al.
Expert Opinion on Pharmacotherapy|May 28, 2013
An expert opinion on pharmacologic approaches to reducing the cardiotoxicity of childhood acute lymphoblastic leukemia therapiesPatricia Zerra, Thomas R Cochran, Vivian I Franco, et al.
Leukemia & Lymphoma|September 13, 2006
The relevance of information generated by in vitro experimental models to clinical doxorubicin cardiotoxicitySteven E Lipshultz, Harvey Cohen, Steven D Colan, et al.
Current Opinion in Pediatrics|August 21, 2018
Cardiovascular disease in survivors of childhood cancerNeha Bansal, Shahnawaz M Amdani, Kelley K Hutchins, et al.
AIDS (London, England)|July 23, 2003
Cardiovascular risk factors, monitoring, and therapy for HIV-infected patientsSteven E Lipshultz, Stacy D Fisher, Wyman W Lai, et al.
Cardiology Research and Practice|February 19, 2011
Cardiovascular effects in childhood cancer survivors treated with anthracyclinesVivian I Franco, Jacqueline M Henkel, Tracie L Miller, et al.
Pageof 29

Showing results (41-50 of 284) with videos related to

Sort By:
Pageof 29
Translational Pediatrics|November 22, 2018
When is early septal myectomy in children with hypertrophic cardiomyopathy justified?Neha Bansal, Paul Barach, Shahnawaz M Amdani, et al.
American Heart Journal|February 26, 2008
Associations between neurohormonal and inflammatory activation and heart failure in childrenChristopher Ratnasamy, Daniel D Kinnamon, Steven E Lipshultz, et al.
Cardio-Oncology (London, England)|February 3, 2021
An Invitation from the Editors of Cardio-OncologySteven E Lipshultz, Giorgio Minotti, Joseph Carver, et al.
JAMA|March 19, 2026
Caffeinated Coffee and Atrial FibrillationSachin A Shah, Steven E Lipshultz, N A Mark Estes
British Journal of Clinical Pharmacology|September 5, 2016
Prevention of cardiotoxicity among survivors of childhood cancerKelley K Hutchins, Hani Siddeek, Vivian I Franco, et al.
Expert Opinion on Pharmacotherapy|May 28, 2013
An expert opinion on pharmacologic approaches to reducing the cardiotoxicity of childhood acute lymphoblastic leukemia therapiesPatricia Zerra, Thomas R Cochran, Vivian I Franco, et al.
Leukemia & Lymphoma|September 13, 2006
The relevance of information generated by in vitro experimental models to clinical doxorubicin cardiotoxicitySteven E Lipshultz, Harvey Cohen, Steven D Colan, et al.
Current Opinion in Pediatrics|August 21, 2018
Cardiovascular disease in survivors of childhood cancerNeha Bansal, Shahnawaz M Amdani, Kelley K Hutchins, et al.
AIDS (London, England)|July 23, 2003
Cardiovascular risk factors, monitoring, and therapy for HIV-infected patientsSteven E Lipshultz, Stacy D Fisher, Wyman W Lai, et al.
Cardiology Research and Practice|February 19, 2011
Cardiovascular effects in childhood cancer survivors treated with anthracyclinesVivian I Franco, Jacqueline M Henkel, Tracie L Miller, et al.
Pageof 29